Pak Fah Yeow International Limited (0239.HK)
HKD 2.44
(0.41%)
HKD 2.44
(0.41%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 907.46 Million HKD | 10.24% |
| 2022 | 823.13 Million HKD | -1.74% |
| 2021 | 837.74 Million HKD | 5.32% |
| 2020 | 795.39 Million HKD | -12.77% |
| 2019 | 911.85 Million HKD | -0.33% |
| 2018 | 914.84 Million HKD | 1.79% |
| 2017 | 898.77 Million HKD | 17.66% |
| 2016 | 763.86 Million HKD | -1.09% |
| 2015 | 772.28 Million HKD | -0.09% |
| 2014 | 772.98 Million HKD | 13.23% |
| 2013 | 682.63 Million HKD | 5.08% |
| 2012 | 649.62 Million HKD | 25.19% |
| 2011 | 518.92 Million HKD | 6.49% |
| 2010 | 487.32 Million HKD | 12.91% |
| 2009 | 431.6 Million HKD | 21.03% |
| 2008 | 356.62 Million HKD | -10.73% |
| 2007 | 399.47 Million HKD | 0.77% |
| 2006 | 396.43 Million HKD | 3.93% |
| 2005 | 381.44 Million HKD | 62.0% |
| 2004 | 235.45 Million HKD | 10.29% |
| 2003 | 213.49 Million HKD | -1.01% |
| 2002 | 215.67 Million HKD | 7.81% |
| 2001 | 200.04 Million HKD | -32.47% |
| 2000 | 296.23 Million HKD | 3.08% |
| 1999 | 287.37 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 935.06 Million HKD | 0.0% |
| 2023 FY | 907.46 Million HKD | 10.24% |
| 2023 Q4 | 907.46 Million HKD | 0.0% |
| 2023 Q2 | 913.56 Million HKD | 0.0% |
| 2022 Q4 | 823.13 Million HKD | 0.0% |
| 2022 Q2 | 823.47 Million HKD | 0.0% |
| 2022 FY | 823.13 Million HKD | -1.74% |
| 2021 Q2 | 833.69 Million HKD | 0.0% |
| 2021 Q4 | 837.74 Million HKD | 0.0% |
| 2021 FY | 837.74 Million HKD | 5.32% |
| 2020 FY | 795.39 Million HKD | -12.77% |
| 2020 Q2 | 818.78 Million HKD | 0.0% |
| 2020 Q4 | 795.39 Million HKD | 0.0% |
| 2019 FY | 911.85 Million HKD | -0.33% |
| 2019 Q4 | 911.85 Million HKD | 0.0% |
| 2019 Q2 | 941.72 Million HKD | 0.0% |
| 2018 FY | 914.84 Million HKD | 1.79% |
| 2018 Q2 | 922.91 Million HKD | 0.0% |
| 2018 Q4 | 914.84 Million HKD | 0.0% |
| 2017 Q4 | 898.77 Million HKD | 0.0% |
| 2017 Q2 | 859.24 Million HKD | 0.0% |
| 2017 FY | 898.77 Million HKD | 17.66% |
| 2016 Q2 | 754.14 Million HKD | 0.0% |
| 2016 Q4 | 763.86 Million HKD | 0.0% |
| 2016 FY | 763.86 Million HKD | -1.09% |
| 2015 FY | 772.28 Million HKD | -0.09% |
| 2015 Q4 | 772.28 Million HKD | 0.0% |
| 2015 Q2 | 804.72 Million HKD | 0.0% |
| 2014 FY | 772.98 Million HKD | 13.23% |
| 2014 Q4 | 772.98 Million HKD | 0.0% |
| 2014 Q2 | 742.55 Million HKD | 0.0% |
| 2013 Q4 | 682.63 Million HKD | 0.0% |
| 2013 FY | 682.63 Million HKD | 5.08% |
| 2013 Q2 | 676.98 Million HKD | 0.0% |
| 2012 Q4 | 649.62 Million HKD | 0.0% |
| 2012 Q2 | 575.92 Million HKD | 0.0% |
| 2012 FY | 649.62 Million HKD | 25.19% |
| 2011 Q2 | 538.66 Million HKD | 0.0% |
| 2011 FY | 518.92 Million HKD | 6.49% |
| 2011 Q4 | 518.92 Million HKD | 0.0% |
| 2010 Q2 | 457.71 Million HKD | 0.0% |
| 2010 Q4 | 487.32 Million HKD | 0.0% |
| 2010 FY | 487.32 Million HKD | 12.91% |
| 2009 Q4 | 431.6 Million HKD | 0.0% |
| 2009 FY | 431.6 Million HKD | 21.03% |
| 2008 FY | 356.62 Million HKD | -10.73% |
| 2007 FY | 399.47 Million HKD | 0.77% |
| 2006 FY | 396.43 Million HKD | 3.93% |
| 2005 FY | 381.44 Million HKD | 62.0% |
| 2004 FY | 235.45 Million HKD | 10.29% |
| 2003 FY | 213.49 Million HKD | -1.01% |
| 2002 FY | 215.67 Million HKD | 7.81% |
| 2001 FY | 200.04 Million HKD | -32.47% |
| 2000 FY | 296.23 Million HKD | 3.08% |
| 1999 FY | 287.37 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 95.97% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | 29.5% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | 56.687% |
| Qianhai Health Holdings Limited | 478.11 Million HKD | -89.8% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 68.607% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 67.906% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | 47.464% |
| PuraPharm Corporation Limited | 843.96 Million HKD | -7.524% |
| SSY Group Limited | 11.96 Billion HKD | 92.417% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | 34.653% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 73.975% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.666% |